CIK 0001649904 · Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462159271
- Phone
- 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Technical Officer sold 3,984 shares at an average $38.47 ($153,259)
- 4 Option exercise EVP, Head of International acquired 10,375 shares (option exercise)
- 4 Open-market sale Corporate Controller & CAO sold 368 shares at $41.76 ($15,368)
- 4 Open-market sale Chief Technical Officer sold 18,235 shares at $40.34 ($735,600)
- 4 Open-market sale EVP, Head of North America sold 18,235 shares at an average $38.77 ($707,005)
- 4 Open-market sale Chief Financial Officer sold 15,515 shares at $39.22 ($608,498)
- 4 Open-market sale Chief Technical Officer sold 15,515 shares at $39.22 ($608,498)
- 4 Open-market sale President and CEO sold 45,494 shares at $39.22 ($1,784,275)
- 4 Open-market sale EVP, Head of International sold 16,000 shares at $39.22 ($627,520)
- 4 Open-market sale EVP, Head of North America sold 15,515 shares at $39.22 ($608,498)
- 4 Open-market sale Chief Human Resources Officer sold 15,515 shares at $39.22 ($608,498)
- 4 Grant or award President and CEO acquired 99,000 shares (grant or award)
- 4 Grant or award EVP, Head of International acquired 33,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Human Resources Officer acquired 33,750 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 33,750 shares (grant or award)
- 4 Grant or award Chief Technical Officer acquired 33,750 shares (grant or award)
- 4 Grant or award EVP, Head of North America acquired 33,750 shares (grant or award)
Page 8 of 22 · 430 filings